<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Kymera Therapeutics, Inc. (KYMR) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/kymr/filings</link>
    <description>Latest company filings for Kymera Therapeutics, Inc. (KYMR) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 04:35:43 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/kymr/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726005075/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-005075</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526239224/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-239224</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526230730/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-230730</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-05-19.]]></description>
      <pubDate>Tue, 19 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526229656/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-229656</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-05-19.]]></description>
      <pubDate>Tue, 19 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000189761226000493/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001897612-26-000493</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[KYMR: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000090221926000204/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902219-26-000204</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726004332/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-004332</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526217041/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-217041</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000031506626001229/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-001229</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526193967/kymr-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-193967</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526193957/kymr-20260430.htm</link>
      <guid isPermaLink="false">0001193125-26-193957</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000196922326000476/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001969223-26-000476</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526192146/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192146</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526191619/kymr_ars_2025.pdf</link>
      <guid isPermaLink="false">0001193125-26-191619</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526191550/kymr_defa14a_2025.htm</link>
      <guid isPermaLink="false">0001193125-26-191550</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526191495/kymr-20260428.htm</link>
      <guid isPermaLink="false">0001193125-26-191495</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000145161226000006/xslF345X06/form4-04242026_080445.xml</link>
      <guid isPermaLink="false">0001451612-26-000006</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526177400/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-177400</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003700/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003700</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000162828026026599/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001628280-26-026599</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000162828026026598/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001628280-26-026598</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000145161226000004/xslF345X06/form4-04162026_100449.xml</link>
      <guid isPermaLink="false">0001451612-26-000004</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-16.]]></description>
      <pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526159539/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-159539</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-16.]]></description>
      <pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526159538/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-159538</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-16.]]></description>
      <pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003490/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003490</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000162828026025281/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001628280-26-025281</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000162828026025280/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001628280-26-025280</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003449/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003449</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-14.]]></description>
      <pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000162828026025115/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001628280-26-025115</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-14.]]></description>
      <pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526151393/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151393</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526149706/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-149706</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-09.]]></description>
      <pubDate>Thu, 09 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003152/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003152</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003151/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003151</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526138372/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-138372</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526138371/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-138371</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003094/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003094</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726003091/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003091</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526129170/d122194d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-129170</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[KYMR: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000010290926001649/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-001649</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526124367/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124367</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726002913/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002913</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726002864/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002864</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-118032</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000195004726002488/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002488</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526102630/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-102630</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000145161226000002/xslF345X05/form4-03042026_040326.xml</link>
      <guid isPermaLink="false">0001451612-26-000002</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526091986/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091986</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526091985/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091985</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526091984/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091984</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[KYMR: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1815442/000119312526091983/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091983</guid>
      <description><![CDATA[Kymera Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>